SUBSCRIBE
SUBSCRIBE

Arcellx Inc.

NEWS
Drug Development
BioSpace’s Latest Clinical Report Highlights Successes and Failures in 2Q2021
In its 2Q2021 Clinical Report, BioSpace highlights drugs that were greenlit for clinical studies, faced clinical and regulatory hurdles and some who saw regulatory wins.
July 14, 2021
 · 
5 min read
 · 
Alex Keown
BioCapital
Arcellx Raises $115 Million Series C to Advance Next-Generation CAR-T Therapies
Arcellx, based in Gaithersburg, Maryland, closed on a Series C financing round worth $115 million.
April 13, 2021
 · 
3 min read
 · 
Mark Terry
BioCapital
Pushing to Improve Immunotherapies, Arcellx Raises $85 Million in Series B
The company plans to use the funds raised to advance the ARC-T and sparX programs, including development of a bivalent BCMA-targeted therapy in multiple myeloma and a CD123-targeted treatment in acute myeloid leukemia.
October 3, 2019
 · 
2 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Press Releases
Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel
February 23, 2026
 · 
12 min read
Press Releases
Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel’s D-Domain Binder
February 5, 2026
 · 
8 min read
Press Releases
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
January 22, 2026
 · 
6 min read
Press Releases
Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma
December 8, 2025
 · 
10 min read
Press Releases
Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition
November 19, 2025
 · 
2 min read
Press Releases
Arcellx Provides Third Quarter 2025 Financial Results
November 5, 2025
 · 
4 min read
Press Releases
Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition
November 3, 2025
 · 
6 min read
Press Releases
Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference
September 4, 2025
 · 
2 min read
Press Releases
Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights
August 8, 2025
 · 
8 min read
Press Releases
Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025
May 22, 2025
 · 
2 min read
Load More